Credit Suisse’s Adagene ADAG Stock Holding History

Credit Suisse’s Portfolio ADAG Stock Details ADAG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-605,638	Closed	-$10.9M	–	4434
2021 Q1	$10.9M	Buy	+605,638	New	+$13.8M	0.01%	1529

Other funds holding ADAG

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

MICM

Matthews International Capital Management San Francisco, California $292M AUM 75.01% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

CII

Capital International Inc Los Angeles, California $13B AUM 31.88% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

SVI

Strategic Vision Investment Hong Kong $157M AUM 125.87% 1-Year Est. Return

Credit Suisse's ADAG Position: Q2 2021 in Review

Credit Suisse sold out of Adagene (ADAG) in Q2 2021, closing a stake of 605,638 shares — an estimated $10.9M sold.

Credit Suisse first reported a position in ADAG in Q1 2021 and held it in 1 quarter. The position peaked at $10.9M in Q1 2021. 16 funds tracked by Wall St. Rank hold ADAG as of Q2 2021.

Credit Suisse reported no remaining Adagene position as of Q2 2021 after selling out during the quarter.
Credit Suisse sold 605,638 Adagene shares in Q2 2021, an estimated $10.9M.
Credit Suisse first reported a position in Adagene in Q1 2021 and held it in 1 quarter.
Credit Suisse's Adagene position peaked at $10.9M in Q1 2021.
16 funds tracked by Wall St. Rank held Adagene as of Q2 2021.

Based on Credit Suisse's 13F filing for Q2 2021, filed 16 Aug 2021.